US50107A1043 - Common Stock
KRONOS BIO INC
NASDAQ:KRON (10/29/2024, 4:30:02 PM)
0.981
+0 (+0.19%)
Kronos Bio, Inc. is a clinical development biopharmaceutical company. The company is headquartered in San Mateo, California and currently employs 61 full-time employees. The company went IPO on 2020-10-09. The firm is focused on developing therapeutics that target the deregulated transcription that causes cancer and other serious diseases. The company is developing KB-0742, its internally discovered oral cyclin dependent kinase 9 (CDK9) inhibitor, for the treatment of MYC-amplified and others transcriptionally addicted solid tumors. The company has initiated the Phase 2 portion of its Phase 1/2 clinical trial for KB-0742. The company is also developing KB-9558, which inhibits the lysine acetyltransferase (KAT) domain of p300, a critical node of the IRF4 TRN. IRF4 is a key transcription factor driver in multiple myeloma and KB-9558 selectively targets its activity. Its scientific focus is on developing medicines that target deregulated transcription, the hallmark of cancer and other serious diseases. Using its Small Molecule Microarray (SMM) platform or other approaches, it can generate and advance small molecule starting points into drug development candidates.
KRONOS BIO INC
1300 S. El Camino Real, Suite 400
San Mateo CALIFORNIA 94402
P: 16507815200
CEO: Norbert Bischofberger
Employees: 58
Website: https://www.kronosbio.com/
– Preclinical data demonstrate that inhibiting the p300 KAT domain reactivates p53 in HPV-driven tumors resulting in anti-tumor activity –
– Preclinical data demonstrate that inhibiting the p300 KAT domain reactivates p53 in HPV-driven tumors resulting in anti-tumor activity –...
– Data show that p300 KAT inhibitor KB-9558 was highly selective against human papillomavirus (HPV) oncoproteins E6 and E7, and therefore drove anti-tumor...
– KB-7898, a p300 KAT inhibitor, is the Company's first development candidate for autoimmune diseases and originates from its proprietary discovery engine...
Here you can normally see the latest stock twits on KRON, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: